Unter den Marken unserer mehr als 25 Partner sticht TargetMol hervor
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Endet am 31. Dez.( 8 verbleibende Tage )
Eberconazole
CAS:Eberconazole, a potent antifungal, is an imidazole derivative effective against dermatophytes. Administered topically.Formel:C18H14Cl2N2Farbe und Form:SolidMolekulargewicht:329.22Justicidin B
CAS:Justicidin B: anticancer, proapoptotic, inhibits bone resorption & platelets, antiviral, fungicidal, antiprotozoal.Formel:C21H16O6Farbe und Form:SolidMolekulargewicht:364.35D-threo-PDMP
CAS:D-threo-PDMP inhibits glucoceramide synthase, cutting cell surface glycosphingolipids and hindering neurite growth.Formel:C23H38N2O3Farbe und Form:SolidMolekulargewicht:390.56JNJ-49095397
CAS:<p>JNJ-49095397 (RV568) is a p38 MAPK-α and p38 MAPK-γ kinase inhibitor for the study of respiratory syncytial virus infection.</p>Formel:C34H36N6O4Reinheit:98.33% - 99.04%Farbe und Form:SolidMolekulargewicht:592.69PKCiota-IN-1
CAS:<p>PKCiota-IN-1: Strong PKC-ι inhibitor (IC50=2.7 nM); also blocks PKC-α/ε (IC50s=45/450 nM).</p>Formel:C25H22FN5OFarbe und Form:SolidMolekulargewicht:427.47FITM
CAS:FITM is a potent negative allosteric modulator of mGlu1 receptor(Ki : 2.5 nM).Formel:C18H18FN5OSReinheit:97.25%Farbe und Form:SolidMolekulargewicht:371.43Azaphilone-9
CAS:<p>AZA-9 inhibits cancer growth by blocking HuR-ARE RNA binding; IC50=1.2μM.</p>Formel:C21H23BrO5Farbe und Form:SolidMolekulargewicht:435.31TNKS1/2-IN-1
CAS:<p>TNKS1/2-IN-1: potent inhibitor for cancer, fibrosis research; pIC50 7.1-8.2.</p>Formel:C26H23F4N3O4Farbe und Form:SolidMolekulargewicht:517.47VEGFR-3-IN-1
CAS:VEGFR-3-IN-1, a potent VEGFR3 inhibitor (IC50=110.4 nM), hinders tumor growth and VEGFR3 signaling, affecting HDLEC and MDA-MB cell proliferation/migration.Formel:C29H29ClF3N7OSReinheit:99.95%Farbe und Form:SolidMolekulargewicht:616.1Naloxonazine
CAS:<p>Naloxonazine, a potent, selective opiate mu-1 (μ1) antagonist, also influences leishmania through the modulation of host coding function.</p>Formel:C38H42N4O6Farbe und Form:SolidMolekulargewicht:650.76IMD-vanillin
CAS:IMD-vanillin is a novel compound characterized as an imidazoquinolinone-derived dimer with NF-κB immunomodulatory properties.Formel:C37H45N7O4Reinheit:98%Farbe und Form:SolidMolekulargewicht:651.8IMD-catechol
CAS:IMD-catechol: an imidazoquinolinone-based dimer with NF-κB activity; improves CT26 cancer treatment, low toxicity.Formel:C31H34N6O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:538.64CDK4/6-IN-15
CAS:CDK4/6-IN-15: Oral, selective CDK4/6 inhibitor, halts cancer cell growth, G1 arrest, suppresses Rb phosphorylation.Formel:C21H27FN8SFarbe und Form:SolidMolekulargewicht:442.5618:0-22:6 DG
CAS:1-Stearoyl-2-docosahexaenoyl-sn-glycerol (18:0-22:6 DG) is a diacylglycerol capable of binding to RasGRP and modulating the activation of MAP kinases.Formel:C43H72O5Farbe und Form:SolidMolekulargewicht:669.03EC330
CAS:EC330, a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range.Formel:C30H32F2O2Reinheit:97.83%Farbe und Form:SolidMolekulargewicht:462.57NCGC00138783
NCGC00138783 blocks CD47/SIRPα interaction; IC50 of 50 µM.Formel:C30H28F7N7O5SFarbe und Form:SolidMolekulargewicht:731.64TRK/ALK-IN-1
TRK/ALK-IN-1: Potent dual TRK & ALK inhibitor; IC50s: 2.2nM (TRKA), 9.3nM (ALK WT), 38nM (ALK L1196M); cancer research potential.Formel:C31H35ClF2N8O2SFarbe und Form:SolidMolekulargewicht:657.18Triphen diol
CAS:Triphen diol, a phenol diol, fights pancreatic cancer & cholangiocarcinoma, inducing apoptosis via caspase-dependent & -independent paths.Formel:C22H20O4Farbe und Form:SolidMolekulargewicht:348.39ChemR23-IN-3
<p>ChemR23-IN-3 is a potent thiazole-based ChemR23 inhibitor with an IC 80 value of 12 nM.</p>Formel:C31H33N5O5S2Farbe und Form:SolidMolekulargewicht:619.75Epothilone E
CAS:<p>Epothilone E, a derivative of epothilone, functions by inhibiting microtubule protein activity, thereby halting cell division and exhibiting anti-tumor</p>Formel:C26H39NO7SFarbe und Form:SolidMolekulargewicht:509.66Aramchol
CAS:Aramchol (C20-FABAC), a mix of arachidic & cholic acid, lessens cholesterol crystallization & dissolves crystals in bile.Formel:C44H79NO5Reinheit:≥95%Farbe und Form:SolidMolekulargewicht:702.1eIF4A3-IN-17
CAS:<p>eIF4A3-IN-17, a silvestrol analogue, disrupts eIF4F assembly; EC50: 0.9-15 nM. Used in cancer pathogenesis research.</p>Formel:C28H25NO7Farbe und Form:SolidMolekulargewicht:487.5eIF4A3-IN-18
CAS:eIF4A3-IN-18, a silvestrol analogue with EC50s: 0.8/35/2 nM, inhibits eIF4F complex and is cytotoxic (LC50: 0.06 nM) for cancer research.Formel:C29H28N2O6Farbe und Form:SolidMolekulargewicht:500.54Palazestrant
CAS:Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with a HER2 inhibitor.Formel:C28H36FN3OReinheit:97.55%Farbe und Form:SolidMolekulargewicht:449.6G4/HDAC-IN-1
<p>G4/HDAC-IN-1, a G4/HDAC dual inhibitor, IC50 1.1 µM, blocks TNBC growth, useful in cancer research.</p>Formel:C36H49ClFN7O4Farbe und Form:SolidMolekulargewicht:698.27JBSNF-000028
<p>JBSNF-000028: potent oral NNMT inhibitor; IC50s—human 0.033 μM, monkey 0.19 μM, mouse 0.21 μM; aids insulin sensitivity & weight loss.</p>Formel:C11H13N3Reinheit:99.23%Farbe und Form:SolidMolekulargewicht:187.24hDHODH-IN-11
CAS:hDHODH-IN-11: potent hDHODH inhibitor, IC50 7.2 nM, low cytotoxicity, for AML research.Formel:C24H23N3O3Farbe und Form:SolidMolekulargewicht:401.46Miridesap
CAS:<p>Miridesap (GSK2315698) rapidly depletes SAP in blood, cerebrospinal fluid, and amyloid deposits via liver clearance.</p>Formel:C16H24N2O6Reinheit:≥95%Farbe und Form:SolidMolekulargewicht:340.3715-PGDH-IN-1
CAS:15-PGDH-IN-1: potent oral 15-PGDH inhibitor, IC50=3nM, useful for tissue repair research.Formel:C24H22N4O2Farbe und Form:SolidMolekulargewicht:398.46CDK4/6-IN-14
CAS:CDK4/6-IN-14: potent CDK4/6 inhibitor, IC50s 10/16 nM, >60-fold selectivity over CDKs 1/2/7/9, selective across 205 kinases.Formel:C24H27ClFN7OFarbe und Form:SolidMolekulargewicht:483.97Dynamin IN-1
CAS:Dynamin IN-1 is a potent dynamin inhibitor with an IC 50 value of 1.0 µM .Formel:C23H24N2OFarbe und Form:SolidMolekulargewicht:344.45Zidesamtinib
CAS:<p>Zidesamtinib (NVL-520) is a ROS1 fusion and resistance mutation inhibitor that inhibits ROS1 and can be used to study non-small cell lung cancer.</p>Formel:C22H22FN7OReinheit:99.74%Farbe und Form:SolidMolekulargewicht:419.455Fazamorexant
CAS:Fazamorexant (YZJ-1139) is a powerful orexin receptor antagonist effective for insomnia research.Formel:C25H25FN4O2Farbe und Form:SolidMolekulargewicht:432.49Gumelutamide
CAS:Gumelutamide, a tetrahydropyridopyrimidine compound, functions as both an antiandrogen and an antineoplastic agent by acting as an androgen antagonist.Formel:C22H21ClN6OFarbe und Form:SolidMolekulargewicht:420.89Darizmetinib
CAS:Darizmetinib (HRX215) is an MKK4 inhibitor.Formel:C21H17F2N5O3SReinheit:98.03% - 99.57%Farbe und Form:SolidMolekulargewicht:457.45DRAK1/2-IN-1
CAS:DRAK1/2-IN-1 is a potent inhibitor targeting both DRAK1 and DRAK2, displaying dissociation constants (Kd) of 1 µM and 6 µM, respectively.Formel:C22H24N2O3SFarbe und Form:SolidMolekulargewicht:396.5BCR-ABL-IN-7
CAS:BCR-ABL-IN-7 is an inhibitor of ABL kinase activity in WT and T315I mutants.BCR-ABL-IN-7 can be used in chronic myeloid leukemia (CML) research.Formel:C19H16FN3O3SReinheit:98.28%Farbe und Form:SolidMolekulargewicht:385.41NUCC-0000323
CAS:NUCC-0000323: potent SOD1 inhibitor, curbs expression, used in ALS research.Formel:C15H13BrN4SFarbe und Form:SolidMolekulargewicht:361.26THZ2
CAS:THZ2 (CDK7-IN-1), an analog of THZ1, is a potent and selective CDK7 inhibitor(IC50:13.9 nM),with the potential to treat Triple-negative breast cancer (TNBC).Formel:C31H28ClN7O2Reinheit:98.28%Farbe und Form:SolidMolekulargewicht:566.05Falcarindiol
CAS:Falcarindiol is an orally active natural polyacetylene compound, anti-inflammatory and antiproliferative. inhibits NO production, suppressing iNOS expression.Formel:C17H24O2Reinheit:99.38%Farbe und Form:SolidMolekulargewicht:260.37Sycosterol A
<p>Sycosterol A is an α-synuclein (α-syn) inhibitory sterol .</p>Formel:C27H48O9SFarbe und Form:SolidMolekulargewicht:548.73Anserinone B
CAS:Anserinone B: Antifungal, antibacterial; inhibits S.fimicola (50%), A. furfuraceus (37%); cytotoxic to human tumor cells (GI50=4.4 µg/mL).Formel:C11H14O4Farbe und Form:SolidMolekulargewicht:210.23Dictyostatin
CAS:Dictyostatin: potent microtubule stabilizer & anticancer agent with antiproliferative effects; researched for tauopathies.Formel:C32H52O6Farbe und Form:SolidMolekulargewicht:532.75Inuviscolide
CAS:Inuviscolide induces apoptosis, G2/M arrest in melanoma, and has anti-cancer, anti-inflammatory effects.Formel:C15H20O3Farbe und Form:SolidMolekulargewicht:248.32ZINC00640089
CAS:<p>ZINC00640089: Selective LCN2 inhibitor; curbs SUM149 cell growth and AKT activity; useful for IBC research.</p>Formel:C20H13F3N2O2Reinheit:98.41% - 99.80%Farbe und Form:SolidMolekulargewicht:370.32Actinoquinol
CAS:Actinoquinol, a compound effective in absorbing UVB radiation, plays a crucial role in protecting the human eye from photooxidative and other oxidativeFormel:C11H11NO4SFarbe und Form:SolidMolekulargewicht:253.27KG-501
CAS:KG-501 (Naphthol AS-E phosphate) is a cAMP response element-binding protein (CREB) inhibitor(IC50 : 6.89 μM).Formel:C17H13ClNO5PReinheit:97.81%Farbe und Form:SolidMolekulargewicht:377.72Rosolic Acid
CAS:Rosolic Acid activates Nrf2, boosts angiogenesis, reduces inflammation, deters apoptosis, aids pancreatic cells, and shields ECs from stress.Formel:C19H14O3Farbe und Form:SolidMolekulargewicht:290.31(S)-JDQ-443
CAS:<p>(S)-JDQ-443, an isomer of JDQ-443, is a selective, potent oral KRAS G12C inhibitor with antitumor properties.</p>Formel:C29H28ClN7OFarbe und Form:SolidMolekulargewicht:526.03Octotiamine
CAS:Octotiamine (TATD), a Vitamin B1 analogue and component of the vitamin complex, is utilized in research related to Vitamin B1 deficiency.Formel:C23H36N4O5S3Farbe und Form:SolidMolekulargewicht:544.75Aflibercept
CAS:<p>Aflibercept has a wide range of applications in life science related research.</p>Farbe und Form:LiquidTGFβRI-IN-6
CAS:<p>TGFβRI-IN-6 is a potent TGFβRI inhibitor with an IC50 value of 0.55 nM.TGFβRI-IN-6 has the potential to enhance anti-tumour immunity.</p>Formel:C17H10F4N6Farbe und Form:SolidMolekulargewicht:374.3Cyprodenate
CAS:Cyprodenate (Actebral) is a potent orally active brain-activating agent with appetite-suppressing properties, useful in studying metabolic.Formel:C13H25NO2Farbe und Form:SolidMolekulargewicht:227.34c-Met-IN-16
CAS:c-Met-IN-16 is a c-Met inhibitor that can be used for cancer research .Formel:C21H17F2N9OFarbe und Form:SolidMolekulargewicht:449.42LEM-14-1189
CAS:<p>LEM-14-1189 inhibits NSD1/2/3 (IC50: 418/111/60 μM), targets nuclear receptors, and may treat cancer and blood diseases.</p>Formel:C35H34N6O5S2Reinheit:98.06%Farbe und Form:SolidMolekulargewicht:682.81FT011
CAS:<p>FT011, a direct anti-fibrotic agent,attenuates cardiac remodelling and dysfunction in experimental diabetic cardiomyopathy.</p>Formel:C20H17NO5Reinheit:98.98%Farbe und Form:SolidMolekulargewicht:351.35DPNB-ABT594
DPNB-ABT594, a nitrobenzyl-caged ABT594, selectively activates α4β2 over α7 nAChRs; used to study Ca²⁺ signaling in MHb.Formel:C31H46ClN3O11Farbe und Form:SolidMolekulargewicht:672.16eeAChE-IN-2
CAS:eeAChE-IN-2 is a potent inhibitor of eeAChE, exhibiting inhibitory potency with an IC50 of 2 nM.Formel:C37H40N8O5SFarbe und Form:SolidMolekulargewicht:708.83(Rac)-SHIN2
CAS:(Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor for the study of T-cell acute lymphoblastic leukemia (T-ALL).Formel:C23H26N4O3Reinheit:98.165% - 99.48%Farbe und Form:SolidMolekulargewicht:406.48Masofaniten
CAS:Masofaniten (EPI-7386) is an orally active androgen receptor (AR) inhibitor with antitumor activity for the study of prostate and breast cancer.Formel:C24H24Cl2N4O4SReinheit:98.42% - 98.66%Farbe und Form:SolidMolekulargewicht:535.44IMD-ferulic
<p>IMD-ferulic, a compound that forms covalent bonds, acts as an NF-κB modulator, enhancing the adjuvanticity of small molecule immune potentiators.</p>Formel:C36H41N7O4Farbe und Form:SolidMolekulargewicht:635.76photoCORM-1
photoCORM-1: a CORM with real-time CO monitoring via color change, exhibits cellular uptake and anti-tumor activity.Formel:C33H32Cl2N2O6Farbe und Form:SolidMolekulargewicht:623.52photoCORM-2
CAS:photoCORM-2 releases CO, changes color for real-time monitoring, has good cellular uptake, and anti-tumor properties.Formel:C17H13NO3Farbe und Form:SolidMolekulargewicht:279.29hGGPPS-IN-3
CAS:13h (hGGPPS-IN-3), a strong C2-ThP-BPs hGGPPS blocker, triggers MM cell apoptosis and shows in vivo anti-myeloma effects.Formel:C21H19BrN4O7P2SReinheit:98%Farbe und Form:SolidMolekulargewicht:613.31β-Estradiol 17-acetate
CAS:<p>β-Estradiol 17-acetate (1,3,5(10)-Estratriene-3,17β-diol 17-acetate) is a metabolite of estradiol.</p>Formel:C20H26O3Reinheit:98.11% - 99.88%Farbe und Form:SolidMolekulargewicht:314.42BAY 1214784
CAS:<p>BAY 1214784: potent, oral hGnRH-R antagonist, reduces LH levels, low variability, good tolerance, may research uterine fibroids.</p>Formel:C29H26ClF4N3O5S2Farbe und Form:SolidMolekulargewicht:672.11Bis-Pro-5FU
CAS:Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.Formel:C10H7FN2O2Farbe und Form:SolidMolekulargewicht:206.17Hsp90-IN-17
CAS:Hsp90-IN-17 (Example 5) is an inhibitor of HSP90, applicable in researching proliferative diseases, including cancer and neurodegenerative conditions.Formel:C21H20N4O7Farbe und Form:SolidMolekulargewicht:440.41HIF-2α-IN-7
CAS:HIF-2α-IN-7 is a hypoxia inducible factor 2α (HIF-2α) inhibitor.Formel:C18H9F6NO2Farbe und Form:SolidMolekulargewicht:385.26L-Afegostat
CAS:<p>L-Afegostat (5-epi-Isofagomine), an iminosugar, inhibits glycosidase and β-Glucosidase (K i 30 μM), aids in carbohydrate synthesis.</p>Formel:C6H13NO3Farbe und Form:SolidMolekulargewicht:147.17PF-06455943
CAS:PF-06455943: LRRK2 inhibitor, IC50=3nM, PET radioligand, used for ADME/neuro PK & Parkinson's research.Formel:C17H14FN5OFarbe und Form:SolidMolekulargewicht:323.32GDC-0575
CAS:<p>GDC-0575 (ARRY-575) is a highly-selective oral small-molecule Chk1 inhibitor(IC50 of 1.2 nM).</p>Formel:C16H20BrN5OReinheit:≥95%Farbe und Form:SolidMolekulargewicht:378.27SIRT2-IN-11
CAS:SIRT2-IN-11 (AEM1), a SIRT2 inhibitor (IC50 18.5μM), induces apoptosis and affects p53, used in cancer research.Formel:C21H22N2OFarbe und Form:SolidMolekulargewicht:318.41eIF4A3-IN-9
CAS:eIF4A3-IN-9, a silvestrol analogue, disrupts eIF4F complex assembly; EC50s: 29/450/80 nM (myc/tub-LUC, MB-231 cells); for cancer research.Formel:C28H27NO8Farbe und Form:SolidMolekulargewicht:505.52METTL3-IN-1
CAS:<p>METTL3-IN-1 is a polyheterocyclic compound, acts as METTL3 inhibitor .</p>Formel:C25H24FN5O2Farbe und Form:SolidMolekulargewicht:445.49METTL3-IN-2
CAS:METTL3-IN-2, a potent METTL3 inhibitor, exhibits an IC50 value of 6.1 nM, effectively impairing the proliferation of Caov3 cancer cells.Formel:C25H26N8OFarbe und Form:SolidMolekulargewicht:454.53METTL3-IN-3
CAS:METTL3-IN-3 is a polyheterocyclic compound, acts as METTL3 inhibitor .Formel:C26H28BrFN6O2Farbe und Form:SolidMolekulargewicht:555.44PF-07054894
CAS:PF-07054894: potent CCR6 antagonist, targets GPCR, for inflammatory bowel disease research.Formel:C24H30N6O4Farbe und Form:SolidMolekulargewicht:466.53cis-ccc_R08
CAS:cis-ccc_R08 infection . cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor .Formel:C22H19ClO6Farbe und Form:SolidMolekulargewicht:414.84PARP10-IN-2
CAS:<p>PARP10-IN-2 is a potent inhibitor of PARP10, a mono-ADP-ribosyltransferase, with an IC50 value of 3.64 μM for human PARP10.PARP10-IN-2 also inhibited PARP2 and</p>Formel:C14H10N2O2Reinheit:99.27%Farbe und Form:SolidMolekulargewicht:238.24PCSK9-IN-13
CAS:PCSK9-IN-13 is a potent inhibitor of PCSK9, effectively preventing the binding of PCSK9 to low-density lipoprotein (LDL) receptors through its mechanism ofFormel:C30H33N5O2Farbe und Form:SolidMolekulargewicht:495.62Vemtoberant
CAS:Vemtoberant is a β3 adrenergic antagonist used in β3-related disorder research like heart failure.Formel:C29H37N3O8S2Farbe und Form:SolidMolekulargewicht:619.75BDP5290
CAS:BDP5290 is a potent inhibitor of both ROCK and MRCK(IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.)Formel:C17H18ClN7OReinheit:97.22%Farbe und Form:SolidMolekulargewicht:371.82HSP90-IN-20
CAS:HSP90-IN-20, a potent inhibitor of HSP90, exhibits an IC50 of ≤10 μM, indicating its potential application in cancer research.Formel:C26H32N4O4Farbe und Form:SolidMolekulargewicht:464.56NLRP3-IN-14
CAS:NLRP3-IN-14, potent selective NLRP3 inhibitor, KD 5.87μM; IC50 0.131μM for IL-1β; for inflammation research.Formel:C27H28N2O4Farbe und Form:SolidMolekulargewicht:444.52NLRP3-IN-15
CAS:NLRP3-IN-15: potent, selective NLRP3 inflammasome inhibitor; IC50 0.114 μM for IL-1β; for inflammation research.Formel:C22H19NO4Farbe und Form:SolidMolekulargewicht:361.39NLRP3-IN-16
CAS:NLRP3-IN-16: potent NLRP3 inflammasome inhibitor; IC50=0.065μM; curbs IL-1β; used in inflammation studies.Formel:C25H25NO5Reinheit:98%Farbe und Form:SolidMolekulargewicht:419.47THRX-144644
CAS:THRX-144644: lung-specific ALK5 inhibitor, 0.14 nM IC50, no systemic TGFβ toxicity.Formel:C26H28ClF2N7Farbe und Form:SolidMolekulargewicht:512ONO-0740556
CAS:ONO-0740556 is a potent agonist of the Gi-coupled human lysophosphatidic acid receptor 1 (LPA1), exhibiting an EC50 value of 0.26 nM.Formel:C20H34NO6PFarbe und Form:SolidMolekulargewicht:415.46NLRP3-IN-13
CAS:<p>NLRP3-IN-13 is an NLRP3 inhibitor that inhibits NLRP3-associated inflammation.NLRP3-IN-13 can be used in the study of neurological disorders and inflammation.</p>Formel:C19H15N3O3SReinheit:99.16%Farbe und Form:SolidMolekulargewicht:365.41MALT1-IN-11
CAS:<p>MALT1-IN-11: MALT1 inhibitor, IC50 <10-100 nM, reduces IL10, for cancer/autoimmune research.</p>Formel:C20H16F4N8OFarbe und Form:SolidMolekulargewicht:460.39CU-CPT9b
CAS:<p>CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM).</p>Formel:C16H13NO2Reinheit:98.1%Farbe und Form:SolidMolekulargewicht:251.28c-Met-IN-14
CAS:c-Met-IN-14: selective c-Met kinase inhibitor, IC50 2.89 nM, anticancer, stops G2/M phase, induces A549 cell apoptosis.Formel:C34H38ClFN4O7SFarbe und Form:SolidMolekulargewicht:701.2PARP1-IN-12
PARP1-IN-12: potent PARP1 inhibitor, IC50 2.99 nM, triggers cell apoptosis, G2/M arrest, induces DSBs in BRCA-deficient cells.Formel:C43H56FN5O5Farbe und Form:SolidMolekulargewicht:741.93PARP7-IN-12
CAS:PARP7-IN-12, a potent inhibitor targeting PARP7, exhibits an IC50 of 7.836 nM. This compound is applicable in cancer research.Formel:C23H27ClF3N5O5Farbe und Form:SolidMolekulargewicht:545.94PARP-2-IN-3
CAS:<p>PARP-2-IN-3 is used in the study of breast cancer as a PARP-2 inhibitor with antitumor activity that induces apoptosis (apoptosis) and necrosis in cancer cells.</p>Formel:C20H20ClN3O3Reinheit:99.33%Farbe und Form:SolidMolekulargewicht:385.84hCAIX-IN-16
CAS:hCAIX-IN-16 (Compound 12d), an inhibitor of hCA IX, exhibits inhibition constants (K i) of 190.0 nM for hCA IX and 187.9 nM for hCA XII.Formel:C20H20N8O2SReinheit:98%Farbe und Form:SolidMolekulargewicht:436.49hCAIX-IN-15
CAS:hCAIX-IN-15 is a potent inhibitor of human carbonic anhydrase IX (hCA IX) with an inhibition constant (Ki) of 38.8 nM, exhibiting broad-spectrum anticancerFormel:C18H14FN7O2SReinheit:98%Farbe und Form:SolidMolekulargewicht:411.41LIXIVAPTAN
CAS:Lixivaptan (VPA-985) is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM)Formel:C27H21ClFN3O2Reinheit:98.36%Farbe und Form:SolidMolekulargewicht:473.93hCAIX-IN-14
CAS:hCAIX-IN-14 is a potent inhibitor of human CA IX with a K i value of 134.8 nM .Formel:C11H17ClN6O2SFarbe und Form:SolidMolekulargewicht:332.81
